AbstractThere are two critical stages in the retroviral reprogramming of somatic cells to produce human induced pluripotent stem cell (hiPSC) lines. One is the production of high titer virus required to reprogram somatic cells; the other is identification of true hiPSC colonies from heterogeneous cell populations, and their isolation and expansion to generate a sustainable, pluripotent stem cell line. Here we describe simple, time-saving methods to address the current difficulties at these two critical junctures. First, we have developed a method to increase the number of infectious viral units 600-fold. Second, we have developed a TRA-1-81-based positive selection column method for isolating “true” hiPSCs from the heterogeneous cell popula...
Background: Disease modeling with patient-derived induced pluripotent stem cells (iPSCs) is a powerf...
In the field of regenerative medicine, the development of induced pluripotent stem (iPS) cells may r...
Current methods to derive induced pluripotent stem cell (iPSC) lines from human dermal fibroblasts b...
AbstractThere are two critical stages in the retroviral reprogramming of somatic cells to produce hu...
SummaryCell banking, disease modeling, and cell therapy applications have placed increasing demands ...
There is growing recognition of the potential value of human induced pluripotent stem cells (hiPSC) ...
Genomic manipulation of human pluripotent stem cells (hPSCs) has become essential to introduce genet...
AbstractLarge-scale production of human induced pluripotent stem cells (hiPSCs) by robust and econom...
SummaryDirect reprogramming of human fibroblasts to a pluripotent state has been achieved through ec...
SummaryGenetic engineering of human induced pluripotent stem cells (hiPSCs) via customized designer ...
En 2006 et 2007, les équipes de Yamanaka et Thomson réalisent la reprogrammation de cellules somatiq...
En 2006 et 2007, les équipes de Yamanaka et Thomson réalisent la reprogrammation de cellules somatiq...
Human induced pluripotent stem cells (hiPSCs), derived from easily obtainable skin cells, possess en...
Here we describe some of the crucial steps to generate induced pluripotent stemcells (iPSCs) usingmR...
We describe the generation and characterization of two human induced pluripotent stem cell (hiPSCs) ...
Background: Disease modeling with patient-derived induced pluripotent stem cells (iPSCs) is a powerf...
In the field of regenerative medicine, the development of induced pluripotent stem (iPS) cells may r...
Current methods to derive induced pluripotent stem cell (iPSC) lines from human dermal fibroblasts b...
AbstractThere are two critical stages in the retroviral reprogramming of somatic cells to produce hu...
SummaryCell banking, disease modeling, and cell therapy applications have placed increasing demands ...
There is growing recognition of the potential value of human induced pluripotent stem cells (hiPSC) ...
Genomic manipulation of human pluripotent stem cells (hPSCs) has become essential to introduce genet...
AbstractLarge-scale production of human induced pluripotent stem cells (hiPSCs) by robust and econom...
SummaryDirect reprogramming of human fibroblasts to a pluripotent state has been achieved through ec...
SummaryGenetic engineering of human induced pluripotent stem cells (hiPSCs) via customized designer ...
En 2006 et 2007, les équipes de Yamanaka et Thomson réalisent la reprogrammation de cellules somatiq...
En 2006 et 2007, les équipes de Yamanaka et Thomson réalisent la reprogrammation de cellules somatiq...
Human induced pluripotent stem cells (hiPSCs), derived from easily obtainable skin cells, possess en...
Here we describe some of the crucial steps to generate induced pluripotent stemcells (iPSCs) usingmR...
We describe the generation and characterization of two human induced pluripotent stem cell (hiPSCs) ...
Background: Disease modeling with patient-derived induced pluripotent stem cells (iPSCs) is a powerf...
In the field of regenerative medicine, the development of induced pluripotent stem (iPS) cells may r...
Current methods to derive induced pluripotent stem cell (iPSC) lines from human dermal fibroblasts b...